Navigation Links
The Lancet Makes Research More Accessible for Healthcare Professionals With New App for iPad
Date:1/6/2012

LONDON, January 6, 2012 /PRNewswire/ --

The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.

"In this new mobile and tablet age, you have to think about how a doctor seeks and uses the information they need," explains Scott Virkler, SVP e-Products Global Medical Research, Elsevier Health Sciences. "iPad gave us the opportunity to rewrite the rules according to the needs of our readers and provide them a convenient solution. With this article-based navigation app, we've created an entirely new model that responds to our readers' need to get to the articles they want, when they want."

The app gives subscribers convenient access to the latest articles published in The Lancet, The Lancet Oncology, The Lancet Neurology and The Lancet Infectious Diseases. Articles are sent to users and categorized by topic for an easy, at-a-glance overview. Users can annotate articles, share them with colleagues and create alerts and bookmark favorites. They can also search the journal database from the app and download articles for immediate or future use, either on or offline. 

The Lancet App is one of many apps Elsevier is developing for healthcare professionals. "We have an extensive, robust mobile app development program," added Virkler. "Healthcare professionals are on the leading edge of this exciting new publishing medium."

The Lancet App is available for free from the App Store on iPad or at http://www.itunes.com/appstore. Selected content is available for all viewers. Subscribers to The Lancent have access to all published content.

Media contact
Tony Kirby
Media Relations Manager
The Lancet Press Office
32 Jamestown Road
Camden
London
NW1 7BY

Tel: +44(0)20-7424-4949
Mob: +44(0)7920-592635
E-mail: tony.kirby@lancet.com


'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet
2. The Lancets New Online Medical Journal Helps Clinicians and Medical Researchers Find Practice-Changing Evidence Quickly and Easily
3. Inverseons Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet
4. Research in Autism Encyclopedia Shows No Link to Children With Autism, Supports Lancet Retraction
5. Pirfenidone Phase 3 Results Published Today in The Lancet
6. Observant LLC Makes the 2008 Inc. 5000 List
7. Varian, Inc. Board of Directors Makes Officer Changes
8. Life Science Alley: R&D Makes German Medical Technologies Top in Europe
9. JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market
10. Advanced Instruments Makes Strategic Investment in Cantimer, Inc.
11. Nanotechnology makes supertelescopes much more sensitive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
Breaking Biology News(10 mins):